| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Expression in Breast Cancer1
Department of Surgery, Stanford University School of Medicine, Stanford, California 94305-5494
Gene amplification and loss of heterozygosity are alterations to
chromosomal structure whereby tumor cells alter patterns of gene
expression. We have identified a novel mechanism of gene regulation in
which cancer cells predominantly express one of the two alleles of a
gene. Estrogen receptor (ER)-
is overexpressed in hormone-responsive
breast cancer compared with normal breast epithelial cells. Using a
polymorphism of codon 10, we examined allele-specific expression of the
four different ER promoters in MCF-7 breast cancer cells and primary
tumors. Monoallelic amplification of expression (MAX) for all four ER
promoters was identified, resulting in an allelic preference of
>100-fold. MAX was the result of an amplification of allele copy
number and a preference to transcribe the amplified allele. The effect
of MAX was most significant for the promoters clustered near the 1'
exon, whereas the expression from the distant H promoter mirrored
template copy number. MAX of the ER gene was not found to occur in
normal endometrial or breast tissue. As a novel mechanism in cancer
genetics, MAX can result in functional homozygosity at a gene locus.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |